Phanes Therapeutics, Inc.
Records under this name other than the patents Phanes Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Showing 1 to 3 of 3 · Back to Phanes Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,390,679 | Anti-Lag 3 Antibodies and Uses Thereof Lapsed on the fee record Ended Jul 19, 2026 · High confidence | Lapsed on the fee record | Ended Jul 19, 2026 | High confidence |
| US 11,365,242 | Anti-apelin antibodies and uses thereof Lapsed on the fee record Ended Jun 21, 2026 · USPTO record | Lapsed on the fee record | Ended Jun 21, 2026 | USPTO record |
| US 11,306,151 | Anti-TIP-1 antibodies and uses thereof Lapsed on the fee record Ended Apr 19, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 19, 2026 | USPTO record |